Search Results - "Katiyar, Harshita"

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial) by Awasthi, Ashish, Katiyar, Harshita, Rungta, Sumit, Deep, Amar, Kumar, Vinod, Shalimar, Kumar, Ajay, Tiwari, Prachi, Goel, Amit

“…Hepatitis C virus (HCV) is a common cause of liver cirrhosis and hepatocellular carcinoma. Globally, nearly 71 million people have chronic HCV infection, and…”
Get full text

The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies by Wang, Jingjing, Luo, Yuhang, Katiyar, Harshita, Liang, Chen, Liu, Qian

“…Interferons (IFNs) are antiviral cytokines that defend against viral infections by inducing the expression of interferon-stimulated genes (ISGs)…”
Get full text

Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir by Katiyar, Harshita, Tiwari, Prachi, Bhadauria, Dharmendra S, Rai, Praveer, Goel, Amit

Get full text

Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield ® ) in Patients with Liver Cirrhosis by Goel, Amit, Verma, Alka, Tiwari, Prachi, Katiyar, Harshita, Aggarwal, Amita, Khetan, Dheeraj, Mayank, Kishore, Ravi V Krishna, Kumar, Pankaj, Singh, Thakur Prashant, Sheikh, Sabreena, Vaishnav, Manas, Pathak, Piyush, Shalimar

“…Introduction: Data are limited on antibody response to the ChAdOx1 nCoV-19 vaccine (AZD1222; Covishield®) in cirrhosis. We studied the antibody response…”
Get full text

Durability of ChAdOx1 nCoV-19 (Covishield ® ) Vaccine Induced Antibody Response in Health Care Workers by Verma, Alka, Goel, Amit, Katiyar, Harshita, Tiwari, Prachi, Mayank, Sana, Asari, Khetan, Dheeraj, Bhadauria, Dharmendra Singh, Raja, Ajay, Khokher, Neelam, Shalimar, Singh, Ratendra Kumar, Aggarwal, Amita

“…(i) Background: ChAdOx1 nCoV-19 (Covishield®) vaccine is widely used in India. We studied the Covishield® induced antibody response and its durability among…”
Get full text

Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients by Bhadauria, Dharmendra S, Katiyar, Harshita, Goel, Amit, Tiwari, Prachi, Kishore, Ravi V Krishna, Aggarwal, Amita, Verma, Alka, Khetan, Dheeraj, Kaul, Anupma, Yachha, Monika, Behera, Manas Ranjan, Yadav, Brijesh, Prasad, Narayan

“…Kidney transplant recipients (KTRs) are at a much higher risk of complications and death following COVID-19 and are poor vaccine responders. The data are…”
Get full text

SARS-CoV-2 Assembly: Gaining Infectivity and Beyond by Katiyar, Harshita, Arduini, Ariana, Li, Yichen, Liang, Chen

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was responsible for causing the COVID-19 pandemic. Intensive research has illuminated the complex…”
Get full text

Prevalence of hepatitis E viraemia among blood donors: a systematic review by Goel, Amit, Vijay, Halkurike Jayadevappa, Katiyar, Harshita, Aggarwal, Rakesh

“…Background Hepatitis E virus (HEV) is usually transmitted by faecal–oral route. Recent reports have documented HEV viraemia in donated blood units and HEV…”
Get full text

Use of Sofosbuvir/Velpatasvir/Voxilaprevir for Sofosbuvir Nonresponder Genotype 3 HCV Infection in India by Tiwari, Prachi, Katiyar, Harshita, Rai, Praveer, Goel, Amit

“…In India, hepatitis C virus (HCV) infection is treated with sofosbuvir in combination with NS5A inhibitor (Daclatasvir, Ledipasvir, or Velpatasvir). A small…”
Get full text

Profile of bacterial infections in patients with acute on chronic liver failure admitted to Intensive Care Unit and its impact on the patient outcomes by Singh, Rajani, Tiwari, Tanushree, Katiyar, Harshita, Singh, Surender, Mishra, Ajay Kumar, Goel, Amit, Dhiman, Radha Krishan

Get full text

Evaluation of Serum Calprotectin as an Alternative Diagnostic Marker for Intrahepatic Cholestasis of Pregnancy by Katiyar, Harshita, Yadav, Sangeeta, Singh, Surender, Mishra, Ajay Kumar, Pradhan, Mandakini, Lingaiah, Raghavendra, Goel, Amit

“…: Intrahepatic cholestasis of pregnancy (ICP) is characterised by unexplained intense pruritus during pregnancy. While serum bile acid (BA) is the standard…”
Get full text

Seroprotection achieved with standard four-dose schedule of hepatitis B vaccine in people with chronic kidney disease: A real-life data by Singh, Surender, Mishra, Ajay Kumar, Yachha, Monika, Singh, Thakur Prashant, Katiyar, Harshita, Kaul, Anupma, Dhiman, Radha Krishna, Bhadauria, Dharmendra Singh, Goel, Amit

“…Hepatitis B virus (HBV) infection is common in people with chronic kidney diseases (CKD). The guidelines recommend four doses, 2.0 mL each, of HBV vaccine,…”
Get full text

Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance by Goel, Amit, Padmaprakash, Kodavoor, Benjamin, Mercilena, Katiyar, Harshita, Aggarwal, Rakesh

“…Acute hepatitis E virus (HEV) is associated with viremia and faecal excretion of the virus. The information on duration and temporal pattern of viremia and…”
Get full text

Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield) by Dandu, Himanshu, Goel, Amit, Kumar, Manish, Malhotra, Hardeep Singh, Katiyar, Harshita, Agarwal, Monica, Kumar, Neeraj, Pandey, Pragya, Rani, Shivani, Yadav, Geeta

“…Despite the effectiveness of COVID-19 vaccination in reducing the severity of the disease, the demand for booster is increasing in vulnerable populations like…”
Get full text

Profile of patients who failed to achieve sustained virological response with sofosbuvir containing first line antiviral therapy in India by Katiyar, Harshita, Mishra, Ajay Kumar, Goel, Amit, Rungta, Sumit, Rai, Praveer, Dhiman, Radha Krishan, Singh, Rajani, Singh, Surender

Get full text

Antibody response to ChAdOx1 nCoV-19 (Covishield®) vaccine in people on maintenance hemodialysis by Bhadauria, Dharmendra Singh, Tiwari, Prachi, Goel, Amit, Katiyar, Harshita, Kaul, Anupma, Mayank, Aggarwal, Amita, Verma, Alka, Khetan, Dhiraj, Yachha, Monika, Behera, Manas Ranjan, Yadav, Brijesh, Agarwal, Kartik, Prasad, Narayan

“…People on renal replacement therapy (RRT) have a high risk of COVID-19 infection and subsequent death. COVID-19 vaccination is strongly recommended for…”
Get full text

Serum Bile Acid Levels in Women With Intrahepatic Cholestasis of Pregnancy in India by Yadav, Sangeeta, Goel, Amit, Lingaiah, Raghavendra, Pradhan, Mandakini, Katiyar, Harshita, Aggarwal, Rakesh

“…Intrahepatic cholestasis of pregnancy (ICP) manifests as unexplained intense pruritus in the third trimester of pregnancy and is often diagnosed based on…”
Get full text

Hepatitis C Retreatment With First-Line Direct Acting Antiviral Drugs by Goel, Amit, Katiyar, Harshita, Mayank, Tiwari, Prachi, Rungta, Sumit, Verma, Abhai, Deep, Amar, Sana, Asari, Rai, Praveer, Aggarwal, Rakesh

“…Sofosbuvir (S), daclatasvir (D), ledipasvir, or velpatasvir (V) containing first-line hepatitis C virus (HCV) treatment regimens fail to cure viremia in 5–10%…”
Get full text

Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India by Katiyar, Harshita, Goel, Amit, Sonker, Atul, Yadav, Vishwajeet, Sapun, Sadul, Chaudhary, Rajendra, Aggarwal, Rakesh

“…Background Hepatitis E virus (HEV) is transmitted primarily through contaminated water and food. Recently, HEV viremia in blood donors and transfusion-related…”
Get full text

Hepatitis C re-treatment with first line direct acting antiviral drugs by Tiwari, Prachi, Katiyar, Harshita, Rungta, Sumit, Verma, Abhai, Deep, Amar, Rai, Praveer, Aggarwal, Rakesh, Goel, Amit

Get full text